References
- Scott B. C., Aruoma O. I., Evans P. J., O'Neil C., Van der Vliet A., Cross C. E., Tritschler H., Halliwell B. Lipoic and dihydrolipoic acids as antioxidants a critical evaluation. Free Radic. Res. 1994; 20: 119–133
- Ziegler D., Hanefeld M., Ruhnau K. J., Meissner H. P., Lobisch M., Schutte K., Gries F. A. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α‐lipoic acid: a 3‐week multicentre randomised controlled trial (ALADIN study). Diabetologia 1995; 38: 1425–1433
- Ziegler D., Mayer P., Mühlen H., Gries F. A. Effekte einer therapie mit α‐liponsäure Gegenüber Vitamin B bei der diabetischen neuropathie. Diabetes Stoffwechs. 1993; 2: 443–448
- Jacob S., Streeper R. S., Fogt D. L., Hokama J. Y., Tritschler H. J., Dietze G. J., Henriksen E. J. The antioxidant α‐lipoic acid enhances insulin‐stimulated glucose metabolism in insulin‐resistant rat skeletal muscle. Diabetes 1996; 45: 1024–1029
- Tsakiridis T., McDowell H. E., Walker T., Downes C. P., Hundal H. S., Vranic M., Klip A. Multiple roles of phosphatidylinositol 3‐kinase in regulation of glucose transport, amino acid transport and glucose transporters in L6 skeletal muscle cells. Endocrinology 1995; 136: 4315–4322
- Jacob S., Henriksen E. J., Tritschler H. J., Augustin H. J., Dietze G. J. Improvement of insulin‐stimulated glucose disposal in type II diabetes after repeated parenteral administration of thioctic acid. Exp. Clin. Endocrinol. Diabetes 1996; 104: 284–288
- Teichert J., Kern J., Tritschler H.‐J., Ulrich H., Preiß R. Investigations on the pharmacokinetics of α‐lipoic acid in healthy volunteers. Inter. J. Clin. Pharmacol. Therap. 1998; 36: 625–628
- Peter G., Borbe H. O. Absorption of [7,8‐14C]rac‐α‐lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat. Arzneim. Forsch. 1995; 45: 293–299
- Clausen A., Bernkop‐Schnürch A. In vitro evaluation of the permeation enhancing effect of thiolated polycarbophil. J. Pharm. Sci. 2000; 89: 1253–1261
- Takanaga H., Tamai I., Tsuji A. pH‐Dependent and carrier‐mediated transport of salicylic acid across caco‐2 cells. J. Pharm. Pharmacol. 1994; 46: 567–570
- Palm K., Luthman K., Ros J., Grasjo J., Artursson P. Effect of molecular charge on intestinal epithelial drug transport: pH‐dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. 1999; 291: 435–443
- Walton E., Wagner A. F., Bachelor F. W., Peterson L. H., Holly F. W., Folkers K. Synthesis of ( + )‐α‐lipoic acid and its optical antipode. J. Am. Chem. Soc. 1955; 77: 5144–5148
- Lehr C.‐M., Bouwstra J. A., Schacht H. E., Junginger E. H. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 1992; 78: 43–48
- Tomita M., Hayashi M., Awazu S. Comparison of absorption‐enhancing effect between sodium caprate and disodium ethylenediaminetetraacetate in caco‐2 cells. Biol. Pharm. Bull. 1994; 17: 753–755
- Bernkop‐Schnürch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm. 2000; 194: 1–13
- Streitwieser A., Klein H. S. Isotope effects on acidity of deuterated formic, acetic, pivalic, and benzoic acids. J. Am. Chem. Soc. 1963; 85: 2759–2763
- Rupprecht H. Silicium dioxide and silicates in drug delivery. Controlled Drug Delivery, B. W. Müller. APV Band 17 Wiss, VerlagsGesmbH, Stuttgart 1987; 197–225
- Wissenschaftliche Tabellen Geigy8th Ed. Ciba‐Geigy, Basel 1983
- Nordtveit R. J., Varum K. M., Smidsrod O. Degradation of partially N‐acetylated chitosans with hen egg white and human lysozyme. Carbohydr. Polym. 1996; 29: 163–167